siRNA compounds comprising terminal substitutions

The invention relates to modified siRNA compounds which down-regulate target gene expression, to pharmaceutical compositions comprising such compounds and to methods of treating and/or preventing the incidence or severity of various diseases or conditions associated with the genes and/or symptoms as...

Full description

Saved in:
Bibliographic Details
Main Author Avkin-Nachum, Sharon
Format Patent
LanguageEnglish
Published 03.12.2019
Subjects
Online AccessGet full text

Cover

Loading…